Animal Biotechnology Market Report 2026

Animal Biotechnology Market Overview

• Animal Biotechnology market size has reached to $32.89 billion in 2025 • Expected to grow to $53.4 billion in 2030 at a compound annual growth rate (CAGR) of 10.2% • Growth Driver: Elevating Animal Health And Welfare Fueling Growth In The Animal Biotechnology Market • Market Trend: The Role Of The Animal Biotech Resource Page In Advancing The Animal Biotechnology Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Animal Biotechnology Market?

Animal biotechnology refers to the use of science and engineering techniques by which living organisms are modified to benefit humans and other animals. Animal biotechnology is used to modify the genome of animals, known as genetic engineering, to improve their suitability in pharmaceuticals, industrial, and agriculture applications. The main type of product of animal biotechnology include diagnostics tests, vaccines, drugs, reproductive and genetic and feed additives that are animals such as companion and livestock. Diagnostics tests refer to a set of techniques that are used to diagnose a disease or condition of organisms. Animal biotechnology is applied in diagnosis of animal diseases, treatment of animal diseases, preventive care of animals, drug development and other applications and used in laboratories, point-of-care testing/in-house testing, veterinary hospitals & clinics and other end-use.

What Is The Animal Biotechnology Market Growth Forecast?

The animal biotechnology market size is expected to see rapid growth in the next few years. It will grow to $53.4 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to development of precision gene-editing tools, increasing focus on preventive veterinary care, growth of biopharmaceutical applications in animals, rising investments in animal reproductive technologies, adoption of AI and big data for animal health monitoring. Major trends in the forecast period include increasing adoption of genetic engineering in livestock, development of personalized veterinary therapies, growth in immunodiagnostic and molecular testing, expansion of artificial insemination and embryo transfer technologies, rising demand for nutraceuticals and feed additives.

What Is The Driver Of The Animal Biotechnology Market?

The growing awareness regarding animal health and welfare is expected to propel the animal biotechnology market going forward. Animal health and welfare are concerned with how people interact with animals and their responsibility to ensure that the animals in their care are handled appropriately and compassionately. In animal health and welfare, animal biotechnology helps in improving animal productivity via increasing growth, reproduction quality, nutrition, feed utilization, food safety, and others for more efficient utilization of resources. For instance, in May 2023, the Humane Society launched the More Than a Pet campaign, emphasizing the importance of equitable access to veterinary care, particularly for underserved communities. Through this initiative, over 14,800 pets received 64,000 services in 2023 via community outreach programs aimed at improving animal welfare in low-resource areas. The campaign focuses on providing essential veterinary care and support to improve the well-being of animals in underserved regions. Therefore, the growing awareness regarding animal health and welfare is driving the growth of the animal biotechnology industry.

Key Players In The Global Animal Biotechnology Market

Major companies operating in the animal biotechnology market are Zoetis Inc., Boehringer Ingelheim International GmbH, Biogenesis Bago SA, Merck & Co Inc., Virbac, Elanco Animal Health Incorporated, Randox Laboratories Ltd., Santa Cruz Biotechnology Inc., IDEXX Laboratories Inc., IDVet, Heska Corporation, INDICAL BIOSCIENCE GmbH, BioChek BV, Ceva Santé Animale, Dalan Animal Health, Vetigenics, Vetoquinol S.A., Neogen Corporation, Abaxis Inc., Henry Schein Animal Health, Patterson Companies Inc., Covetrus Inc., Phibro Animal Health Corporation, Novartis Animal Health, Bayer AG, Bioniche Life Sciences Inc., Bio-Rad Laboratories Inc., Biovet JSC, Bovogen Biologicals Pty Ltd.

Global Animal Biotechnology Market Trends and Insights

Major companies operating in the animal biotechnology market are innovating new technological products such as Animal Biotech Resource Page to increase their profitability in the market. The Animal Biotech Resource Page is a public library of animal biotechnology resources gathered from worldwide workshops. For instance, in June 2023, International Service for the Acquisition of Agri-biotech Applications, a US-based non-profit organization launched Animal Biotech Resource Page. The resource page includes presentation slides, podcasts, videos, and workshop materials that address the most recent advancements in the sector and the regulatory strategies to be taken into account. The worldwide gatherings provided forums for discussions and agreement building on the subjects. The goal of the animal biotech resource page is to give researchers, regulators, students, and other important players in the animal biotech space the chance to keep learning and discussing the subject in order to foster a deeper comprehension of the technology and maximize its advantages for the environment and society.

What Are Latest Mergers And Acquisitions In The Animal Biotechnology Market?

In September 2023, Zoetis Inc., a US-based drug company, acquired Adivo for an undisclosed amount. The acquisition gives Zoetis access to current species-specific antibody libraries and technological know-how, enabling it to create a variety of cutting-edge veterinary treatments. With the acquisition of Adivo, Zoetis is better equipped to develop therapeutic antibodies for use in companion animals, which assist meet unmet needs in cancer, inflammatory disorders, and other areas for its clients. Adivo is a Germany-based biotechnology company.

What Defines the Animal Biotechnology Market?

The animal biotechnology market includes revenues earned by entities by using animal biotechnology for dogs, cats, horses, poultry, swine, cattle, sheep, goats and fish. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Animal Biotechnology Market Report 2026?

The animal biotechnology market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the animal biotechnology industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.